International Journal of Breast Cancer
ESCI-ISI SCOPUS (2014-2023)
2090-3170
2090-3189
Ai cập
Cơ quản chủ quản: Hindawi Limited , HINDAWI LTD
Lĩnh vực:
OncologyCancer ResearchPharmacology (medical)
Các bài báo tiêu biểu
Drug Resistance and the Role of Combination Chemotherapy in Improving Patient OutcomesResistance to cancer chemotherapy is a common phenomenon especially in metastatic breast cancer (MBC), a setting in which patients typically have had exposure to multiple lines of prior therapy. The subsequent development of drug resistance can result in rapid disease progression during or shortly after completion of treatment. Moreover, cross-class multidrug resistance limits patient trea... ... hiện toàn bộ
Tập 2013 - Trang 1-15 - 2013
Evaluation of Antiproliferative Activity of Red Sorghum Bran Anthocyanin on a Human Breast Cancer Cell Line (MCF-7)Breast cancer is a leading cause of death in women worldwide both in the developed and developing countries. Thus effective treatment of breast cancer with potential antitumour drugs is important. In this paper, human breast cancer cell line MCF-7 has been employed to evaluate the antiproliferative activity of red sorghum bran anthocyanin. The present investigation showed that red sorghum ... ... hiện toàn bộ
Tập 2011 - Trang 1-6 - 2011
Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast CancerThe use of low doses of cytotoxic agents continuously for prolonged periods is an alternative for the treatment of patients with metastatic breast cancer who have developed resistance to conventional chemotherapy. The combination of metronomic chemotherapy with therapeutic vaccines might increase the efficacy of the treatment. Twenty one patients with metastatic breast cancer in progressio... ... hiện toàn bộ
Tập 2011 - Trang 1-6 - 2011
Utilization of Oncotype DX in an Inner City Population: Race or Place?Oncotype DX, a 21-gene-array analysis, can guide chemotherapy treatment decisions for women with ER+ tumors. Of 225 ER+ women participating in a patient assistance trial, 23% underwent Oncotype DX testing: 31% of whites, 21% of blacks, and 14% of Hispanics (P = 0.04 P = 0.001 P = 0.25 P < 0.0001 RR = 1.70 RR = 1.34 hiện toàn bộ
Tập 2013 - Trang 1-3 - 2013
Target Points in Trastuzumab ResistanceEpidermal growth factor (EGF) family of receptors is involved in cell growth and differentiation. The human EGF2 (HER2) lacks natural ligands, and correlation between HER2 levels and carcinogenesis makes the receptor an ideal candidate for targeted therapy in breast cancer. Trastuzumab is a humanized antibody applied against HER2-positive breast tumors in clinic. Metastatic tumors respond ... ... hiện toàn bộ
Tập 2012 - Trang 1-9 - 2012